Breakfast of Champions: Ketamine Infusion for Chronic Pain and Depression
Ketamine was developed in 1962 as a less hallucinogenic and shorter acting anesthetic agent than phencyclidine. It was first used in humans in 1964. Since then, ketamine has been used for a variety of purposes, including the management of acute pain, chronic pain, and depression. The history of ketamine will be examined, and the current evidence available supporting its use in chronic pain and depression will be presented.
Available Credit
- 1.00 AANP
- 1.00 ACCME (All Other)
- 1.00 ACCME (MD/DO Only)
- 1.00 ACPE Pharmacy
- 1.00 ANCC
- 1.00 APA